Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Europeans Launch Drug Discovery Initiative
by Michael McCoy
February 11, 2013
| A version of this story appeared in
Volume 91, Issue 6
Large drug companies are joining with academic institutions, small firms, and nonprofits in Europe to create a drug discovery initiative called the European Lead Factory. Key to the effort will be assembly of a screenable collection of about a half-million small molecules, 300,000 of which will be contributed by seven big drug companies and 200,000 of which will be synthesized by academics and small firms. The European Lead Factory will have a budget of about $260 million, mostly from European Commission research funding and participating drug companies.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X